No doubt I shall not be the only person to rise to John Bache's bait (December 2003 JRSM 1 ). He gives an unsubstantiated opinion that elderly drivers are a serious cause of accidents because their reaction times, memories, concentration and visual acuity are poor. May I give an equally unsubstantiated alternative view? I suggest that elderly people might not cause more accidents, because they drive more slowly, take fewer risks, are less prone to 'road rage' or being provoked by it and have a life-time's driving experience behind them. Furthermore, the elderly have learned not to mix drink, drugs and driving and the drugs they take may be less hazardous than so-called recreational ones. Physical frailty is not a problem with modern cars, except for getting in and out of them (why are car doors not made hinged from the rear, as in London taxis?). I agree that requirements for driving licences need changing; for example, visual fields are as important as visual acuity, at all ages.
The only hard evidence I know of to support my view is that insurance premiums are not universally loaded against the old as they are against the young, and insurers are very knowledgeable about risk.
Conflict of interest I am 80 years of age. I try to avoid driving after dark. 
A K Adams

Potential of vaginal microbicides in HIV control
The editorial by Professor Kotwal (January 2004 JRSM 1 ) provides a very welcome commentary on South Africa's improved approach to HIV/AIDS. I am surprised, however, that he makes no mention of the potential role of vaginal microbicides in curbing the epidemic. These products are in an advanced stage of development and, like AIDS vaccines, are the subject of clinical trials taking place in several countries, including South Africa. Microbicides are gels containing selected anti-infective agents, for women to insert before sexual intercourse in order to protect themselves and their partners from HIV and other sexually transmitted infections. 2 Some 20 microbicides have been successfully tested in human safety studies and several of them are scheduled to begin large-scale field trials this year to find out how well they protect women at high risk of HIV, with the results expected some 3 years later. Unlike condoms, they do not create a physical barrier to reduce sexual pleasure, and-crucially-they are controlled by the woman and will thus make a vital contribution to enhancing women's empowerment. Microbicides are not intended to replace other vital prevention measures such as those based on health education messages, male and female condoms-or AIDS vaccines when they become available-but will give people a wider choice of potentially life-saving methods of protection.
